S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA

• Chung Kok,
• Verity Saunders,
• Phuong Dang,
• Naranie Shanmuganathan,
• Deborah White,
• Susan Branford,
• David Yeung,
• Timothy Hughes

Affiliations

Chung Kok

1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia

Verity Saunders

1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia

Phuong Dang

1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia

Naranie Shanmuganathan

1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia

Deborah White

1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia

Susan Branford

2 The University of Adelaide, Adelaide Medical School, Adelaide, Australia

David Yeung

1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia

Timothy Hughes

1 SAHMRI (South Australian Health and Medical Research Institute), Precision Cancer Medicine, Adelaide, Australia